Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Cuthbertson

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma productsC Prowse, B Cuthbertson, M Turner
Lancet (London, England)|April 17, 1982
Contamination of plasma for fractionation: a design solutionJ G Watt, R Perry, B Cuthbertson
Annals of Clinical Research|June 1, 1980
Rapid random-donor screening for the selection of viral antibody-containing blood donationsB Cuthbertson, W Hart, R G Sommerville
British Medical Journal (Clinical Research Ed.)|November 22, 1986
Incidence of chickenpox in adults and recruitment of plasma donors for manufacture of zoster immunoglobulinD C MacInnes, B Cuthbertson, R J Crawford
Human Immunology|June 1, 1982
Histocompatibility types and antiviral antibodies in a diverse group of individualsB Cuthbertson, H M Dick, R G Sommerville
Lancet (London, England)|July 4, 1987
Safety of albumin preparations manufactured from plasma not tested for HIV antibodyB Cuthbertson, J G Rennie, D Aw, et al.
Vox Sanguinis|January 1, 1994
Distribution of hepatitis A antibody over a process for the preparation of a high-purity factor VIII concentrateH Hart, A Jones, H Cubie, et al.
Vox Sanguinis|January 1, 1988
Potential contribution of mild pepsin treatment at pH4 to the viral safety of human immunoglobulin productsK G Reid, B Cuthbertson, A D Jones, et al.
Lancet (London, England)|November 19, 1983
Non-A, non-B hepatitis from intravenous immunoglobulinA G Welch, B Cuthbertson, R V McIntosh, et al.
Clinical and Experimental Immunology|February 1, 1987
Increased half-life of gammaglobulin after prolonged intravenous replacement therapyA M Lever, P L Yap, B Cuthbertson, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2011
Risk reduction strategies for variant Creutzfeldt-Jakob disease transmission by UK plasma productsC Prowse, B Cuthbertson, M Turner
Lancet (London, England)|April 17, 1982
Contamination of plasma for fractionation: a design solutionJ G Watt, R Perry, B Cuthbertson
Annals of Clinical Research|June 1, 1980
Rapid random-donor screening for the selection of viral antibody-containing blood donationsB Cuthbertson, W Hart, R G Sommerville
British Medical Journal (Clinical Research Ed.)|November 22, 1986
Incidence of chickenpox in adults and recruitment of plasma donors for manufacture of zoster immunoglobulinD C MacInnes, B Cuthbertson, R J Crawford
Human Immunology|June 1, 1982
Histocompatibility types and antiviral antibodies in a diverse group of individualsB Cuthbertson, H M Dick, R G Sommerville
Lancet (London, England)|July 4, 1987
Safety of albumin preparations manufactured from plasma not tested for HIV antibodyB Cuthbertson, J G Rennie, D Aw, et al.
Vox Sanguinis|January 1, 1994
Distribution of hepatitis A antibody over a process for the preparation of a high-purity factor VIII concentrateH Hart, A Jones, H Cubie, et al.
Vox Sanguinis|January 1, 1988
Potential contribution of mild pepsin treatment at pH4 to the viral safety of human immunoglobulin productsK G Reid, B Cuthbertson, A D Jones, et al.
Lancet (London, England)|November 19, 1983
Non-A, non-B hepatitis from intravenous immunoglobulinA G Welch, B Cuthbertson, R V McIntosh, et al.
Clinical and Experimental Immunology|February 1, 1987
Increased half-life of gammaglobulin after prolonged intravenous replacement therapyA M Lever, P L Yap, B Cuthbertson, et al.
Pageof 2